Key Developments: ResMed Inc (RMD)
50.07USD
17 May 2013
$0.44 (+0.89%)
$49.80
$49.92
$50.28
$49.76
472,840
1,062,908
$51.40
$29.82
Latest Key Developments (Source: Significant Developments)
Resmed Inc Declares Quarterly Dividend
Resmed Inc announced that it declared a quarterly dividend of $0.17 per share, which will have a record date of May 21, 2013, and be payable on June 18, 2013. Full Article
Resmed Inc Files Lawsuit Against Apex Medical Corp
Apex Medical Corp (Apex) announced that Resmed Inc filed a lawsuit against Apex in California Central District Court, alleging Apex's infringement of its patent right. Details were not disclosed. Full Article
Resmed Inc Announces Changes In Board Of Directors
Resmed Inc announced that effective March 1, 2013, Michael (Mick) Farrell will succeed Dr. Peter C. Farrell as ResMed's chief executive officer (CEO) and be appointed to its board of directors. Robert (Rob) Douglas will become ResMed's president and chief operating officer (COO). Current CEO, chairman of the board and founder, Dr. Farrell, will become executive chairman. Full Article
Resmed Inc Declares Quarterly Dividend
Resmed Inc announced that Board of Directors has declared a quarterly dividend of $0.17 per share, which will have a record date of February 19, 2013, and be payable on March 19, 2013. Full Article
Resmed Inc Declares Quarterly Dividend
Resmed Inc announced that the Board of Directors has today declared a quarterly dividend of $0.17 per share, which will have a record date of November 20, 2012, and be payable on December 18, 2012. Full Article
ResMed Inc. Declares Quarterly Dividend
ResMed Inc. announced that its Board of Directors have declared a quarterly dividend of $0.17 per share, which will have a record date of September 7, 2012, and be payable on September 28, 2012. Full Article
ResMed Inc. Announces Holding Interest Of Perpetual Limited
ResMed Inc. announced that Perpetual Limited has an interest of 78,850,607 ordinary shares, representing 5.07% of the voting power in the Company. Full Article
ResMed Inc. Announces Holding Interest Of JCP Investment Partners Ltd
ResMed Inc. announced that JCP Investment Partners Ltd is holding an interest of 78,431,898 ordinary shares, representing 5.04% of voting power in the Company. Full Article
ResMed Inc. Not To Pay FY 2011 Final Dividend
ResMed Inc. announced that the Company has not declared or recommend any dividend for the year ended June 30, 2011. Full Article
Carefusion Corp And ResMed Inc. Announce Distribution Agreement For U.S. Hospital Market
CareFusion and ResMed Inc. announced a five-year agreement providing CareFusion the exclusive right to distribute the ResMed Stellar 100 and 150 non-invasive ventilators (NIV) and their related accessories into the U.S. institutional healthcare market. The agreement, effective immediately, provides strategic benefits to both companies. For ResMed, it provides a timely introduction of its new ventilation products, with their unique performance, size and mobility features valuable to clinicians, caregivers and patients, via CareFusion's long-standing relationships with U.S. hospitals, long-term acute care and skilled nursing facilities. CareFusion will also market and sell the Stellar 100 and 150 related accessories, including tubing and filters. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
